[Epidermal cytokines, interleukins and the skin].
Delaporte
E
E
INSERM U 209, Hôpital E. Herriot, Lyon.
Nicolas
J F
JF
Thivolet
J
J
D001685:Biological Factors / Q000502:physiology*; D002921:Cicatrix / Q000503:physiopathology; D003115:Colony-Stimulating Factors / Q000502:physiology*; D016207:Cytokines; D004817:Epidermis / Q000032:analysis*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007372:Interferons / Q000502:physiology; D007376:Interleukin-2 / Q000627:therapeutic use; D007378:Interleukins / Q000502:physiology*; D011994:Recombinant Proteins; D012871:Skin Diseases / Q000188:drug therapy / Q000503:physiopathology*
D001685:Biological Factors; D003115:Colony-Stimulating Factors; D016207:Cytokines; D006133:Growth Substances; D007370:Interferon Type I; D007376:Interleukin-2; D007378:Interleukins; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007372:Interferons
Cytokines épidermiques, interleukines et peau.